Dynamics in Post-pandemic Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ661852
Publisher: Date of Publish:
No. of Pages: 136 Category: Medical Devices Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global NASH (Non-alcoholic Steatohepatitis) Biomarkers market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global NASH (Non-alcoholic Steatohepatitis) Biomarkers market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Serum Biomarkers Hepatic Fibrosis Biomarkers Apoptosis Biomarkers Oxidative Stress Biomarkers Others Segmented by End User/Segment Pharma & CRO Industry Hospitals Diagnostic Labs Academic Research Institutes Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey GENFIT SA Pfizer Inc Novo Nordisk A/S Novartis AG Gilead Sciences, Inc. (GILD) Bristol-Myers Squibb Company Boehringer Ingelheim AstraZeneca Allergan Plc
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status and Forecast (2016-2027) 1.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Supply by Company 2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Company 2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Company 2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Company 2.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status by Category 3.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Category Introduction 3.1.1 Serum Biomarkers 3.1.2 Hepatic Fibrosis Biomarkers 3.1.3 Apoptosis Biomarkers 3.1.4 Oxidative Stress Biomarkers 3.1.5 Others 3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Category 3.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Category (2016-2021) 3.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Category (2016-2021) 3.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status by End User/Segment 4.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by End User/Segment 4.1.1 Pharma & CRO Industry 4.1.2 Hospitals 4.1.3 Diagnostic Labs 4.1.4 Academic Research Institutes 4.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by End User/Segment 4.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by End User/Segment (2016-2021) 4.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by End User/Segment (2016-2021) 4.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status by Region 5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Region 5.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Region 5.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Region 5.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 5.3 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 5.4 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 5.5 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 5.6 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 6 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 6.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country 6.1.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021) 6.1.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 7.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country 7.1.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021) 7.1.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 8.1 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country 8.1.1 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 9.1 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country 9.1.1 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021) 9.1.2 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status 10.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country 10.1.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Cost Analysis 11.5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Channel and Distributors Analysis 11.5.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Channel 11.5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors 11.6 NASH (Non-alcoholic Steatohepatitis) Biomarkers Downstream Major Buyers 12 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Category and by End User/Segment 12.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Category 12.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume Forecast by Category 12.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value Forecast by Category 12.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by Category 12.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by End User/Segment 12.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume Forecast by End User/Segment 12.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value Forecast by End User/Segment 12.3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by End User/Segment 13 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Region/Country 13.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Region (2022-2027) 13.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume Forecast by Region (2022-2027) 13.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 GENFIT SA 14.1.1 Company Information 14.1.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.1.3 GENFIT SA NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Pfizer Inc 14.2.1 Company Information 14.2.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.2.3 Pfizer Inc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Novo Nordisk A/S 14.3.1 Company Information 14.3.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.3.3 Novo Nordisk A/S NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Novartis AG 14.4.1 Company Information 14.4.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.4.3 Novartis AG NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Gilead Sciences, Inc. (GILD) 14.5.1 Company Information 14.5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.5.3 Gilead Sciences, Inc. (GILD) NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Bristol-Myers Squibb Company 14.6.1 Company Information 14.6.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.6.3 Bristol-Myers Squibb Company NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Boehringer Ingelheim 14.7.1 Company Information 14.7.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.7.3 Boehringer Ingelheim NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 AstraZeneca 14.8.1 Company Information 14.8.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.8.3 AstraZeneca NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Allergan Plc 14.9.1 Company Information 14.9.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction 14.9.3 Allergan Plc NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com